IL3RA and acute myeloid leukemia: Preclinical studies. Gill et al. in 2014 presented the results of one of the first studies confirming the effectiveness of anti-CD123 CAR-T cells with the 4-1BB co-stimulatory domain in vitro and in vivo on a mouse AML xenograft model.